Search

Your search keyword '"Ortiz Santamaria V."' showing total 63 results

Search Constraints

Start Over You searched for: Author "Ortiz Santamaria V." Remove constraint Author: "Ortiz Santamaria V."
63 results on '"Ortiz Santamaria V."'

Search Results

1. Immunoglobulins in systemic sclerosis management. A large multicenter experience

2. AB1000 ANIFROLUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS. SPANISH NATIONAL REGISTRY IN A REAL-WORLD SETTING

3. OP0225 CHANGES IN TREATMENT PATTERNS AND THEIR INFLUENCE ON THE OUTCOME OF SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE (SSc-ILD) PATIENTS: AN EUSTAR ANALYSIS

4. Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research

5. POS1227 CAPISAS PROJECT: INCIDENCE AND EPIDEMIOLOGY OF ANTISINTETASE SYNDROME IN CATALONIA (SPAIN) BETWEEN 2016 AND 2019

6. PO.2.50 Utility in clinical practice of anti-dsdna autoantibodies vs antidna crithidia luciliae in the diagnosis of systemic lupus erythematosus

7. Persistent inflammation in systemic sclerosis is strongly associated with mortality: a EUSTAR database analysis

8. POS0873 PERSISTENT INFLAMMATION IN SYSTEMIC SCLEROSIS IS STRONGLY ASSOCIATED WITH SEVERE DISEASE AND MORTALITY: AN ANALYSIS FROM THE EUSTAR DATABASE

9. PERSISTENT INFLAMMATION IN SYSTEMIC SCLEROSIS IS STRONGLY ASSOCIATED WITH SEVERE DISEASE AND MORTALITY: AN ANALYSIS FROM THE EUSTAR DATABASE

10. POS0888 EPIDEMIOLOGICAL AND CLINICAL DIFFERENCES BETWEEN ANTI-MDA5 PHENOTYPES: DATA FROM A LARGE COHORT (MEDRA5) STUDY

11. A comparative study on clinical and serological characteristics between patients with rhupus and those with systemic lupus erythematosus and rheumatoid arthritis

12. AB1051 KIKUCHI FUJIMOTO DISEASE, IS IT SLE?

15. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

16. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

18. Update of EULAR recommendations for the treatment of systemic sclerosis

19. Update of EULAR recommendations for the treatment of systemic sclerosis

20. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis. a 10-year longitudinal study from the EUSTAR database

21. Nailfold capillaroscopic findings in primary Sjogren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies

24. AB0451 Rivaroxaban versus warfarin as secondary thromboprophylaxis in patients with antiphospholipid syndrome protocol: a randomized, multicentre, open-label, clinical trial

25. THU0390 Efficacy of Anakinra in Refractory Adult-Onset Still's Disease: Multicenter Open-Label Study of 34 Patients: Table 1

27. SAT0241 Is there any nailfold capillaroscopic pattern in patients with primary sjögren’s syndrome with or without raynaud’s phenomenon and/or positive anti-RO/anti-LA?

33. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort

34. Phenotypes determined by cluster analysis and their survival in the prospective European Scleroderma Trials and Research cohort of patients with systemic sclerosis

35. A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study

36. Similarities and differences between systemic juvenile idiopathic arthritis and adult-onset Still's disease: a multicenter Spanish study.

37. Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis.

38. Value of second-trimester uterine artery pulsatility index in pregnancies with systemic lupus erythematosus and/or antiphospholipid syndrome.

39. Decreasing prevalence of chronic back pain in Catalonia. Analysis of the Catalan Health Survey.

40. A comparative study on clinical and serological characteristics between patients with rhupus and those with systemic lupus erythematosus and rheumatoid arthritis.

42. Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial.

43. Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial.

44. How many patients with rheumatic diseases and TNF inhibitors treatment have latent tuberculosis?

45. A classic mimicker of systemic vasculitis.

46. Efficacy of Anakinra in Refractory Adult-Onset Still's Disease: Multicenter Study of 41 Patients and Literature Review.

47. Nutritional support in patients with systemic sclerosis.

48. Newborns whose mother has autoimmune disease. A community hospitals' experience.

49. Nutrition in systemic sclerosis.

50. Pulmonary aneurysms in microscopic polyangiitis.

Catalog

Books, media, physical & digital resources